KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Adaptive Biotechnologies (ADPT) Income from Continuing Operations (2018 - 2025)

Adaptive Biotechnologies (ADPT) has disclosed Income from Continuing Operations for 8 consecutive years, with 13579000.0 as the latest value for Q4 2025.

  • Quarterly Income from Continuing Operations rose 59.73% to 13579000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 59457000.0 through Dec 2025, up 62.75% year-over-year, with the annual reading at 59457000.0 for FY2025, 62.75% up from the prior year.
  • Income from Continuing Operations hit 13579000.0 in Q4 2025 for Adaptive Biotechnologies, down from 9545000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 9545000.0 in Q3 2025 to a low of 69467000.0 in Q4 2023.
  • Historically, Income from Continuing Operations has averaged 42601100.0 across 5 years, with a median of 46890500.0 in 2024.
  • Biggest five-year swings in Income from Continuing Operations: plummeted 72.94% in 2023 and later soared 129.74% in 2025.
  • Year by year, Income from Continuing Operations stood at 61357000.0 in 2021, then soared by 34.53% to 40169000.0 in 2022, then tumbled by 72.94% to 69467000.0 in 2023, then surged by 51.46% to 33717000.0 in 2024, then skyrocketed by 59.73% to 13579000.0 in 2025.
  • Business Quant data shows Income from Continuing Operations for ADPT at 13579000.0 in Q4 2025, 9545000.0 in Q3 2025, and 25593000.0 in Q2 2025.